Stay updated with breaking news from Cellular Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical...
/PRNewswire/ -- The "Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical...
The project consortium, which consists of 68 Australian and international partners, is being led by Prof Wei Zhang from Flinders University and includes researchers from the ARC Centre of Excellence for Electromaterials Science (ACES). ACES researchers will provide bioengineering and biomaterials expertise for the Marine Bioproducts Cooperative Research Centre (MB-CRC), bringing together the excellence of fabrication skills at the University of Wollongong with the growing research and industry activity in marine bioresources. The MB-CRC includes research, industry and government partners work...
Funding to fast-track the growth of Australia’s next generation of marine bioproducts industries. A team of researchers at the ARC Centre of Excellence for Electromaterial Science (ACES) based at the University of Wollongong (UOW), in conjunction with a consortium of 68 Australian and international partners, has been awarded $59 Million in funding in the latest round of grants from the Federal Government’s Cooperative Research Centres program. The funding will fast-track the growth of Australia’s next generation of marine bioproducts industries and, ACES researchers will provide bioengi...
Synthego, the genome engineering company, today announced the launch of Eclipse™, a new high-throughput cell engineering platform designed to accelerate drug discovery and validation by providing highly predictable CRISPR-engineered cells at scale through the integration of engineering, bioinformatics, and proprietary science. The launch of this unique CRISPR-based platform is driving the company's growing impact in biopharma R&D, reinforcing Synthego's position as the genome engineering leader. Synthego's Eclipse Platform Enables Scalable CRISPR-based Cell Engineering CRISPR-engineere...